Skip to main content

The role of technology, research and innovation in the COVID-19 recovery

Inquiry

In addition to its health impacts, the COVID-19 pandemic has disrupted economic activity, with the OECD estimating that the initial impact on the UK has been a reduction in GDP of more than 25% since the end of March. Research and innovation activity has been affected, with the Campaign for Science and Engineering reporting financial and logistical difficulties for academic institutes, medical research charities and businesses.

This is particularly important given the ability of research and innovation to drive economic growth as the UK seeks to recover from the pandemic, with UKRI having previously estimated that every £1 spent on research and development delivers £7 in economic and social benefit.

The House of Commons Science and Technology Committee will inquire formally into the role of technology, research and innovation in the UK’s economic recovery from COVID-19, as well as the support that the sector itself requires to recover from the pandemic.

Read the call for evidence for more information about this inquiry.

Reports, special reports and government responses

No reports or special reports published.

Oral evidence transcripts

View all oral evidence transcripts
25 November 2021
Inquiry The role of technology, research and innovation in the COVID-19 recovery
Witnesses Andy Street CBE (Mayor at West Midlands Combined Authority), Dr Clive Hickman (Chief Executive at The Manufacturing Technology Centre), Professor Simon Collinson (Director at City-REDI, University of Birmingham), Tony Kinsella (Chief Executive at Lucideon), Stephen Malone (Group CEO at Malone Group), Professor Martin Freer (Director at Energy Research Accelerator (ERA)), and Professor Daniel Smith (Executive Director, Global Cell and Gene Therapy Portfolio at Cobra Biologics)
Committees Science and Technology Committee
Oral Evidence
23 September 2021
Inquiry The role of technology, research and innovation in the COVID-19 recovery
Witnesses Professor Richard Jones (Vice-President for Regional Innovation and Civic Engagement at University of Manchester), Professor Luke Gheorgiou (Deputy President and Deputy Vice-Chancellor at University of Manchester), Simon Cohen (CEO at Innovate Pharmaceuticals), Chris Oglesby (Exec Chair at Bruntwood SciTech, and CEO at Bruntwood), Richard Jeffery (National Director at GC Business), Dr Charles Knight (Associate Dean at University of Salford), Dr Marianne Sensier (Research Fellow at University of Manchester), and James Baker (CEO at Graphene@Manchester, University of Manchester)
Committees Science and Technology Committee
Oral Evidence
21 April 2021
Inquiry The role of technology, research and innovation in the COVID-19 recovery
Witnesses Hetan Shah (Chief Executive at British Academy), Sir Adrian Smith (President at Royal Society), Hilary Reynolds CBE (Chief Executive at Association of Medical Research Charities), Naomi Weir (Head of Innovation at CBI), and Verity Davidge (Director of Central Policy at Make UK)
Committees Science and Technology Committee
Oral Evidence
CRV0068 - The role of technology, research and innovation in the COVID-19 recovery
Witnesses The Manufacturing Technology Centre (MTC)
Committees Science and Technology Committee
Written Evidence
CRV0066 - The role of technology, research and innovation in the COVID-19 recovery
Witnesses LumiraDx
Committees Science and Technology Committee
Written Evidence
CRV0067 - The role of technology, research and innovation in the COVID-19 recovery
Witnesses The Manufacturing Technology Centre (MTC)
Committees Science and Technology Committee
Written Evidence

Contact us

We can’t usually help you with an individual problem or a specific complaint.

  • Email: scitechcom@parliament.uk
  • Phone: 020 7219 2793 (General enquiries) / 020 7219 3172 (Media enquiries) / 18001 20 7219 2793 (text relay)
  • Address: Science and Technology Committee, House of Commons, London, SW1A 0AA